Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening

NCT ID: NCT06898333

Last Updated: 2025-09-25

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 279 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-05-08
• Study Completion Date: 2027-05-31

Brief Summary

The investigators proposal is ripe for executing as the investigators seek to leverage this "natural experiment" initiated by the BJC health system to evaluate the effectiveness of the Pink & Pearl Campaign as an implementation strategy to promote lung cancer screening (LCS) uptake among LCS-eligible women undergoing mammography at BJC West County. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, the research questions and specific aims for this proposal are to: a) evaluate the baseline prevalence of LCS among LCS-eligible women; b) assess whether the Pink & Pearl Campaign increases referrals and uptake/ completion of LCS among LCS-eligible women undergoing screening mammography; and c) evaluate individual and environmental factors influencing LCS uptake, and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.

Conditions

Lung Cancer; Cancer of the Lung

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Participants - scheduled for mammography and eligible for LCS

Women who are scheduled for mammography and are potentially LCS-eligible will be approached by the registration team and will complete a survey. Subjects who were referred for LCS will be contacted and the investigators will gauge their interest in returning for dual breast and lung screening program in future and rate their experience on a patient satisfaction scale.

No interventions assigned to this group

Providers

Providers in the breast radiology service who referred women to LCS. Investigators will gather information on the feasibility, acceptability, and appropriateness of the Pink and Pearl project.

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Undergoing screening mammography
• Between the ages of 50-80 years (inclusive)
• Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years
• Can speak and understand English
• Ability to understand willingness to provide informed consent.

Exclusion Criteria

• Diagnosed with a serious health problem that will likely limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year)

• Subjects with symptoms of lung cancer should get a diagnostic CT scan
• Unable or unwilling to get treatment if lung cancer is found

Eligibility Criteria for Providers:

• Older than 20 years of age

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Washington University School of Medicine

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Beryne Odeny, M.D., MPH, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Washington University School of Medicine

Locations

Barnes-Jewish Hospital West County

Creve Coeur, Missouri, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Beryne Odeny, M.D., MPH, Ph.D.

Role: CONTACT

beryne@wustl.edu

314-362-1183

Facility Contacts

Beryne Odeny, M.D, MPH, Ph.D.

Role: primary

beryne@wustl.edu

314-362-1183

Related Links

http://www.siteman.wustl.edu

Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Other Identifiers

202412064

Identifier Type: -

Identifier Source: org_study_id